- $5.50bn
- $5.56bn
- $1.04bn
Nutrition ingredients maker Balchem's Q3 sales edge past estimates
Balchem Corp reports results for the quarter ended June 30 - Earnings Summary
Balchem Q2 sales beat estimates on growth across segments
Brief: Balchem Corp Enters Amendment No. 1 To Credit Agreement On July 24, 2026 - SEC Filing
Nutrition ingredients supplier Balchem's Q1 sales rise 8%, beat estimates
Brief: Balchem Corporation Reports Fourth Quarter And Full Year 2025 Financial Results
Balchem Q4 revenue beats on Human Nutrition and Health unit strength
Brief: Balchem Q4 Sales USD 263.6 Million
Balchem Q3 sales rise 11.5%, beat estimates
Balchem Corp reports results for the quarter ended June 30 - Earnings Summary
Balchem Q2 sales beat analyst expectations
Balchem Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Balchem Q1 Net Income USD 37.1 Million
Balchem Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Balchem Q4 Net Income USD 33.6 Million
Balchem Corp reports results for the quarter ended in September 30 - Earnings Summary
Balchem Corp expected to post earnings of $1.11 a share - Earnings Preview
Balchem Corp reports results for the quarter ended in June - Earnings Summary
Brief: Balchem Q2 EPS USD 0.98